BSL — Bhayani Securities (Pvt) Ltd.
GLAXO logo
GlaxoSmithKline Pakistan LimitedGLAXO

Rs 326.47 ▲ +11.47 (+3.64%)As of close

View GLAXO share price

GlaxoSmithKline Pakistan Limited: Shariah Disclosure for the Half Year ended June 30, 2026

Shariah DisclosureNEUTRAL

Key facts

Disclosure type
Mandatory Shariah compliance disclosure for the half year ended June 30, 2026.
Shariah-compliant income
PKR 31,519.29M, up from PKR 30,300.81M in the previous period.
Shariah non-compliant income
PKR 359.96M, increased from PKR 204.58M.
Shariah-compliant bank balances
PKR 2.85M, slightly up from PKR 2.82M.

GlaxoSmithKline Pakistan Limited has submitted its Shariah compliance disclosure for the half year ended June 30, 2026, in accordance with PSX regulations and the Companies Act, 2017.

  • Disclosure type: Mandatory Shariah compliance disclosure for the half year ended June 30, 2026.
  • Shariah-compliant income: PKR 31,519.29M, up from PKR 30,300.81M in the previous period.
  • Shariah non-compliant income: PKR 359.96M, increased from PKR 204.58M.
  • Shariah-compliant bank balances: PKR 2.85M, slightly up from PKR 2.82M.
  • The company maintains a relationship with Meezan Bank Limited, a Shariah-compliant bank.
Original filing (PDF)
WhatsAppXLinkedIn

About this brief: prepared automatically by BSL’s research systems from the company’s filing with the exchange, per our editorial policy and data methodology. A summary for information, not investment advice — the original filing is the authoritative record.

Trade GLAXO with BSL

Act on this filing with live PSX data, research support, and a broker built for it.

Open an account